Collaboration has become the latest natural phenomenon in business, especially real estate, a topic we're sure to hear about at Bisnow’s 4th Annual Life Sciences Summit on April 29. (Register here.) In life science, there’s “hyper-collaboration,” says BioMed VP for leasing and development Bill Kane, who'll be speaking at our event. This week, BioMed closed on the $308M acquisition of a 1M SF, two-building life science portfolio near Yale University from Winnstanley Enterprises. One building is being built for Alexion, which recently partnered with Moderna Therapeutics, a BioMed tenant at 320 Bent St in East Cambridge. Life science companies thrive on collaboration, flexibility, capital efficiency, and working with trusted partners, he says.
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories
